Contents:

01. Consultee comments on the ACD - Gilead Sciences

02. Consultee comments on the ACD – Hepatitis C Trust

03. Consultee comments on the ACD – HIV i-Base

04. Consultee comments on the ACD – Liver4Life

05. Consultee comments on the ACD – British Association for the Study of the Liver

06. Consultee comments on the ACD – British HIV Association

07. Consultee comments on the ACD – British Society for Gastroenterology

08. Consultee comments on the ACD – Royal College of Pathologists

09. Consultee comments on the ACD – Royal College of Physicians

10. Consultee comments on the ACD – NHS England

11. Commentator comments on the ACD – Public Health England

12. Commentator comments on the ACD – Janssen

13. Commentator comments on the ACD – Merck Sharpe & Dohme

14. Public comments on the ACD received via the NICE website

15. Additional analyses provided by Gilead sciences

16. Response to request for clarification provided by Gilead Sciences

17. Evidence Review Group critique of additional analyses provided by Southampton Health Technology Assessments Centre

18. Response to critique of additional analyses provided by Gilead Sciences

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report. It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.